Myeloma News and Research

RSS
New technique holds promise to screen cancer cells for drug susceptibility

New technique holds promise to screen cancer cells for drug susceptibility

‘Precision Medicine’ may not always be so precise when applied to diverse populations, study says

‘Precision Medicine’ may not always be so precise when applied to diverse populations, study says

Insights from NGLY1 deficiency could provide new approach to treat blood cancers

Insights from NGLY1 deficiency could provide new approach to treat blood cancers

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

New CAR-T cell therapy offers effective option for certain blood cancer patients

New CAR-T cell therapy offers effective option for certain blood cancer patients

TGen awarded $2.5 million SU2C grant to test new method of treating pancreatic cancer

TGen awarded $2.5 million SU2C grant to test new method of treating pancreatic cancer

Cancers linked to obesity account for 40% of all cancers in the US, report states

Cancers linked to obesity account for 40% of all cancers in the US, report states

Trial identifies genetic fault that affects treatment response in leukemia patients

Trial identifies genetic fault that affects treatment response in leukemia patients

Researchers explore new combination approach to treat high-risk soft-tissue sarcomas

Researchers explore new combination approach to treat high-risk soft-tissue sarcomas

Categories of Preference included for recommendations within NCCN Guidelines

Categories of Preference included for recommendations within NCCN Guidelines

Researcher develops bone marrow models to study hematological and musculoskeletal diseases

Researcher develops bone marrow models to study hematological and musculoskeletal diseases

Immune booster could improve effectiveness of vaccines and cancer immunotherapy

Immune booster could improve effectiveness of vaccines and cancer immunotherapy

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

Promising brain cancer vaccine developed at Roswell Park receives orphan drug status from FDA

Promising brain cancer vaccine developed at Roswell Park receives orphan drug status from FDA

UAMS scientists awarded $422,610 NSF grant to study regulation of emotion

UAMS scientists awarded $422,610 NSF grant to study regulation of emotion

Shaping the future of oncology treatment

Shaping the future of oncology treatment

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

FDA advisory committee recommends Novartis' CAR-T therapy for young leukemia patients

FDA advisory committee recommends Novartis' CAR-T therapy for young leukemia patients

Scientists reveal role of cellular prion protein in development of NF2-related tumors

Scientists reveal role of cellular prion protein in development of NF2-related tumors

FDA authorizes marketing of test to aid in diagnoses of serious cancers

FDA authorizes marketing of test to aid in diagnoses of serious cancers